Company / Current Liabilities
TEVA PHARMACEUTICAL INDUSTRIES LTD Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$13.5B
FY2025
5-year range
$11.0B / $13.5B
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
#8 of 213
Health Care
What the data says
Among 213 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the bottom 4% for current liabilities. Current Liabilities has increased for 4 consecutive years, from $11.0B in FY2021 to $13.5B in FY2025.
Based on SEC 10-K filings.
$13.5B in FY2025 with a 5-year CAGR of +0.4%. Top quartile in the Health Care sector.
Increased from $12.2B to $13.5B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +5.5%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Sector benchmark
+747.3% above sector average
Key checks
Key Insights
- TEVA PHARMACEUTICAL INDUSTRIES LTD's current liabilities has grown for 4 consecutive years.
- 5-year CAGR of +0.4%, indicating consistent growth.
- In FY2025, current liabilities increased 5.2% year-over-year.
- Ranks #8 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.5B | +5.2% |
| FY2024 | $12.8B | +4.5% |
| FY2023 | $12.2B | +6.8% |
| FY2022 | $11.5B | +4.0% |
| FY2021 | $11.0B | -16.2% |
| FY2020 | $13.2B | -3.7% |
| FY2019 | $13.7B | -4.5% |
| FY2018 | $14.3B | -20.1% |
| FY2017 | $17.9B | -3.1% |
| FY2016 | $18.5B | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026